- Home
- ROIV vs BG Comparison
ROIV vs BG Comparison
Compare ROIV & BG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | BG |
|---|---|---|
| Founded | 2014 | 1818 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.6B | 22.9B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ROIV | BG |
|---|---|---|
| Price | $26.32 | $122.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $27.44 | ★ $125.29 |
| AVG Volume (30 Days) | ★ 6.9M | 1.8M |
| Earning Date | 02-06-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 2.29% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.91 |
| Revenue | $13,310,000.00 | ★ $70,329,000,000.00 |
| Revenue This Year | N/A | $24.52 |
| Revenue Next Year | $741.42 | $9.98 |
| P/E Ratio | ★ N/A | $24.85 |
| Revenue Growth | N/A | ★ 32.43 |
| 52 Week Low | $8.73 | $68.33 |
| 52 Week High | $27.94 | $124.78 |
Technical Indicators
Market Signals| Indicator | ROIV | BG |
|---|---|---|
| Relative Strength Index (RSI) | 66.81 | 75.24 |
| Support Level | $26.31 | $112.83 |
| Resistance Level | $27.94 | $123.24 |
| Average True Range (ATR) | 0.97 | 4.04 |
| MACD | 0.46 | 0.05 |
| Stochastic Oscillator | 79.45 | 87.72 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About BG Bunge Limited
Bunge Global SA formerly Bunge Ltd is an agribusiness and food company with operations along the farm-to-consumer food chain. The company segments include Agribusiness; Refined and Specialty Oils; Milling; Sugar and Bioenergy and Corporate and Other. It generates maximum revenue from the Agribusiness segment. The company is an oilseed processor and producer of vegetable oils and protein meals, based on processing capacity, a grain processor, the seller of packaged plant-based oils, producer and seller of wheat flour, bakery mixes and corn-based products in North and South America.